AFT Pharmaceuticals to announce half year results on Thursday November 21 2019
AFT Pharmaceuticals (NZX: AFT, ASX: AFP) announced today that it intends to release on Thursday November 21 2019 its half year results for the period ended September 30 2019. The release will be issued at around 09:00.
This will be followed by a presentation by management at 10:00 by teleconference. The presentation material which will be referred to by management will be issued at around 09:00 and will also be available on the company’s website aftpharm.com.
To attend the conference call please dial in on one of the numbers below at least five minutes before the scheduled call time, identify yourself to the operator and provide the following confirmation code: 8476857
Confirmation code: 8476857
Phone numbers:
Australia
+61 2 8038 5221
1800 123 296
New Zealand
+64 9 8876 907
0800 452 782
For more information:
Investors
Malcolm Tubby
CFO, AFT Pharmaceuticals Ltd
Phone: +64 9 488 0232
Email: malcolm@aftpharm.com
Media
Richard Inder
The Project
Phone: 021 645 643
Email: richard@theproject.co.nz
About AFT Pharmaceuticals
AFT is a growing multinational pharmaceutical company that develops, markets and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major pharmaceutical distribution channels: over-the-counter (OTC), prescription and hospital. Our product portfolio comprises both proprietary and in-licensed products, and includes patented, branded and generic drugs. Our business model is to develop and in-license products for sale by our own dedicated sales teams in our home markets of Australia and New Zealand and in certain Southeast Asian markets, and to out-license our products to local licensees and distributors to the rest of the world. For more information: https://www.aftpharm.com/
